These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23154637)

  • 1. miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle.
    Pérez-Andreu V; Teruel R; Corral J; Roldán V; García-Barberá N; Salloum-Asfar S; Gómez-Lechón MJ; Bourgeois S; Deloukas P; Wadelius M; Vicente V; González-Conejero R; Martínez C
    Mol Med; 2013 Jan; 18(1):1466-72. PubMed ID: 23154637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
    Loriot MA; Beaune P
    Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
    Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
    J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle.
    Oldenburg J; Bevans CG; Müller CR; Watzka M
    Antioxid Redox Signal; 2006; 8(3-4):347-53. PubMed ID: 16677080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variant in the promoter region of microRNA‑137 reduces the warfarin maintenance dose in patients with atrial fibrillation.
    Tian Z; Yang Y; Feng Z; Wu D; Yang W; Liu D
    Mol Med Rep; 2019 Jun; 19(6):5361-5367. PubMed ID: 31059093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
    Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
    Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis vitamin K epoxide reductase homologue supports vitamin K-dependent carboxylation in mammalian cells.
    Tie JK; Jin DY; Stafford DW
    Antioxid Redox Signal; 2012 Feb; 16(4):329-38. PubMed ID: 21939388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VKORC1 and the vitamin K cycle.
    Garcia AA; Reitsma PH
    Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study.
    Holzer G; Grasse AV; Zehetmayer S; Bencur P; Bieglmayer C; Mannhalter C
    Transl Res; 2010 Jul; 156(1):37-44. PubMed ID: 20621035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding.
    Spohn G; Kleinridders A; Wunderlich FT; Watzka M; Zaucke F; Blumbach K; Geisen C; Seifried E; Müller C; Paulsson M; Brüning JC; Oldenburg J
    Thromb Haemost; 2009 Jun; 101(6):1044-50. PubMed ID: 19492146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-133a-5p Inhibits the Expression of Osteoblast Differentiation-Associated Markers by Targeting the 3' UTR of RUNX2.
    Zhang W; Wu Y; Shiozaki Y; Sugimoto Y; Takigawa T; Tanaka M; Matsukawa A; Ozaki T
    DNA Cell Biol; 2018 Mar; 37(3):199-209. PubMed ID: 29359964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are involved in its active site regeneration.
    Tie JK; Jin DY; Stafford DW
    J Biol Chem; 2014 Mar; 289(13):9396-407. PubMed ID: 24532791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of VKORC1 interaction partners by split-ubiquitin system and coimmunoprecipitation.
    Schaafhausen A; Rost S; Oldenburg J; Müller CR
    Thromb Haemost; 2011 Feb; 105(2):285-94. PubMed ID: 21103663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
    Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
    Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.
    Ma J; Wang T; Guo R; Yang X; Yin J; Yu J; Xiang Q; Pan X; Tang H; Lei X
    J Drug Target; 2015; 23(6):519-24. PubMed ID: 25714665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV-1 capsid-binding host factor CPSF6 is post-transcriptionally regulated by the cellular microRNA miR-125b.
    Chaudhuri E; Dash S; Balasubramaniam M; Padron A; Holland J; Sowd GA; Villalta F; Engelman AN; Pandhare J; Dash C
    J Biol Chem; 2020 Apr; 295(15):5081-5094. PubMed ID: 32152226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K epoxide reductase: homology, active site and catalytic mechanism.
    Goodstadt L; Ponting CP
    Trends Biochem Sci; 2004 Jun; 29(6):289-92. PubMed ID: 15276181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.